USP General Chapter <1136> is far more than a glossary of storage terms—it is an enforceable standard that protects patients by ensuring that the drug tested in clinical trials reaches the pharmacy shelf in the same condition. For any organization involved in pharmaceutical packaging, warehousing, or distribution, mastering the definitions and operational expectations of <1136> is non-negotiable.
A common point of confusion for readers of the USP-38 is the relationship between General Chapter 1136 and General Chapter 659 "Packaging and Storage Requirements." usp -38 general chapter 1136-
Disclaimer: This article is for informational purposes only and does not replace the official USP–NF text. Always refer to the current official USP–NF compendium for regulatory compliance. USP General Chapter <1136> is far more than
You cannot remove a dose from one unit-dose container and put it into another. Always refer to the current official USP–NF compendium
USP provides specialized guidance for the packaging and application of systems. This general chapter is intended for use by pharmaceutical manufacturers, repackagers, and pharmacists to ensure that drugs are dispensed safely and effectively. Overview of USP General Chapter
The core thesis of Chapter <1136> is simple: The chapter systematically dismantles the myth that final product inspection (visual or automated) is sufficient. Instead, it mandates a lifecycle approach to particulate control, beginning at the packaging design phase.
Unit-of-use containers dispensed directly to patients must be child-resistant (CR) under the Poison Prevention Packaging Act (PPPA).